InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Davidson Matt. Director active across 1 company, notably Adial Pharmaceuticals, INC.. Cumulatively, 5 reports have been published. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Davidson Matt is a declarant linked to Adial Pharmaceuticals, INC. (XNAS), where he is Chief Development Officer. The 5 filings recorded, all dated 2026-06-16 in the sampled filings, are of Attribution nature, and no buy or sell amounts are indicated.